HOME | SUPPORT | °øÁö»çÇ×
 
ÀÛ¼ºÀÏ : 11-06-14 14:13
[Pharsight] Criteria for FDA's Acceptance of Results from Pharmacometrics Approaches
 ±Û¾´ÀÌ : Ƽ¾ØÁ¦ÀÌÅ×Å©
Á¶È¸ : 4,809  
   ppdm-10-info.pdf (68.8K) [11] DATE : 2011-06-14 14:13:37
   ppdm-10.pdf (4.0M) [5] DATE : 2011-06-14 14:13:37
   http://www.pharsight.com/events/eventsonline_archive.php [1033]
   http://mediaserver.aapspharmaceutica.com/meetings/webinars/archives.pd¡¦ [1065]
Criteria for FDA's Acceptance of Results from Pharmacometrics Approaches
An AAPS eLearning Series Webinar

Date: June 2, 2011
Time: 12:45pm - 2:15pm EDT
Speaker: Jogarao Gobburu, PhD, Division of Pharmacometrics, OCP/US FDA
Moderator: Dan Weiner, PhD, Pharsight


Join this webinar for a historical perspective of modeling and simulation (M&S) submissions to FDA, and for insights on strategies to increase the likelihood that M&S results will be acceptable to FDA for review. Questions addressed include: What should be addressed in the submission? For which approaches has FDA received training, and what if a sponsor wants to perform M&S based on some other approach? How are reviewers assigned to specific submissions, and is there a checklist of things they look for? The webinar will include an interactive question and answer session.
[ÀÌ °Ô½Ã¹°Àº Ƽ¾ØÁ¦ÀÌÅ×Å©´Ô¿¡ ÀÇÇØ 2011-06-14 14:15:49 ÀÚ·á½Ç¿¡¼­ À̵¿ µÊ]